Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.1208766 on May 18, 2009

Published online before print May 18, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure 1
Right arrow Buy
Right arrow All Versions of this Article:
jlb.1208766v1
86/3/701    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Alves, B. N.
Right arrow Articles by Hudig, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alves, B. N.
Right arrow Articles by Hudig, D.
(Journal of Leukocyte Biology. 2009;86:701-712.)
© 2009 Society for Leukocyte Biology

Pancreatic lipase-related protein 2 (PLRP2) induction by IL-4 in cytotoxic T lymphocytes (CTLs) and reevaluation of the negative effects of its gene ablation on cytotoxicity

Bryce N. Alves*,1, Jeff Leong*, David L. Tamang*, Viki Elliott*, Jillian Edelnant*, Doug Redelman*, Cherie A. Singer{dagger}, Andrew R. Kuhn{dagger}, Rita Miller{ddagger}, Mark E. Lowe{ddagger} and Dorothy Hudig*

* Department of Microbiology and Immunology, and
{dagger} Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada, USA; and
{ddagger} Children’s Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

1. Correspondence: Mail Stop 320, University of Nevada, Reno, 1664 N. Virginia St, Reno, NV 89557-0046, USA. E-mail: brycea{at}gbis.com

ABSTRACT

Pancreatic lipase-related protein 2 (PLRP2) is induced by IL-4 in vitro in cytotoxic T lymphocyte (CTL) clones and CTLs from immunized wild-type (WT) PLRP2+/+ are more cytotoxic than PLRP2–/– CTLs, suggesting to previous investigators that the lipase PLRP2 might support CTL functions. Here, we further evaluate PLRP2 in CTLs. We found that PLRP2 was optimally induced in splenocytes by 3.5 x 10–8 M IL-4 by day 6 after activation and was restricted to CD8+ T cells. PLRP2 mRNA was detected inconsistently (and at low levels) after activation in the presence of IL-2. Cytotoxicity in 4 h 51Cr assays of WT CTLs was ~3-fold the activity of PLRP2–/– CTLs cultured with IL-4 and, with IL-2, was unexpectedly ~2 fold the activity of PLRP2–/– CTLs. Thus, PLRP2 gene ablation affected short-term (perforin-dependent) cytotoxicity, even under the IL-2 conditions. Other variables failed to account for the reduced cytotoxicity. Granzyme B levels, activation markers, and CD8+ T cell frequencies were similar for WT vs. PLRP2–/– CTLs (with either cytokine). Addition of rPLRP2 to IL-4 induced PLRP2–/– CTLs (or to cytotoxic granule extracts) failed to increase lysis, suggesting that the missing mediator is more than released PLRP2. Cytotoxicity of WT and PLRP2–/– CTLs was similar in 2-day tumor survival assays with IL-4, which can be mediated by perforin-independent mechanisms. We conclude that extracellular PLRP2 lipase is unable to directly augment the cytotoxicity that was lost by PLRP2 ablation and that after reevaluation, the question of what is PLRP2’s role in CD8 T cells is still unanswered.

Key Words: CD8 • pe T cellsrforin • eGFP-P815